Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system
Yanjun Lu, Qian Xu, Shita Zhu · 2024
Read Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system by Yanjun Lu, Qian Xu, Shita Zhu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11688381.txt.
Description
Lu, Xu, and Zhu mine United States drug safety reports for drugs linked to clotting disorders. Coagulopathies can cause dangerous bleeding or clots, and some are triggered by medication. Finding high-risk drugs early helps doctors protect patients who need those treatments.
The team pulled reports tied to coagulopathies from the FDA adverse event system, covering early 2004 to mid-2024. They used signal methods such as the reporting odds ratio and proportional reporting ratio. Strong signals flag drug and event pairs that occur more than expected. The results guide safer prescribing and closer watch on risky drugs.
Catalog record
| CREATOR | Yanjun Lu, Qian Xu, Shita Zhu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |